Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

CX3CL1 Mimetic Peptide to Disrupt Fractalkine Signaling Dysregulation

CX3CL1/CX3CR1 axis; target: CX3CR1 receptor activation · immunomics · -
Composite
0.470
Price
$0.47
Evidence For
0
Evidence Against
0

CX3CL1 Mimetic Peptide to Disrupt Fractalkine Signaling Dysregulation

Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplificatio

CRP → IL-1β → TLR4/MyD88 axis · immunomics · -
Composite
0.540
Price
$0.54
Evidence For
0
Evidence Against
0

Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

Unspecified Mechanismimmunomics
Convergent signals
  • No same-target convergence detected in this selection.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

5/11
dimensions won
CX3CL1 Mimetic Peptide to Disrupt Fracta
10/11
dimensions won
Circulating hs-CRP as Disease-Modifying

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.45
0.55
Evidence
0.45
0.50
Novelty
0.60
0.60
Feasibility
0.35
0.45
Impact
0.40
0.40
Druggability
0.40
0.40
Safety
0.55
0.60
Competition
0.80
0.70
Data
0.40
0.65
Reproducible
0.40
0.55
KG Connect
0.50
0.50

Score Breakdown

DimensionCX3CL1 Mimetic Peptide to DisrCirculating hs-CRP as Disease-
Mechanistic0.4500.550
Evidence0.4500.500
Novelty0.6000.600
Feasibility0.3500.450
Impact0.4000.400
Druggability0.4000.400
Safety0.5500.600
Competition0.8000.700
Data0.4000.650
Reproducible0.4000.550
KG Connect0.5000.500

Evidence

CX3CL1 Mimetic Peptide to Disrupt Fractalkine Signaling Dysr

No evidence citations yet

Circulating hs-CRP as Disease-Modifying Target via Microglia

No evidence citations yet

Debate Excerpts

CX3CL1 Mimetic Peptide to Disrupt Fractalkine Sign

4 rounds · quality: 0.50

Theorist

# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration --- ## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification **Descripti...

Skeptic

# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...

Domain Expert

# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration ## Executive Summary The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...

Synthesizer

```json { "ranked_hypotheses": [ { "rank": 1, "id": "Hypothesis_1", "title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification", "targe...

Circulating hs-CRP as Disease-Modifying Target via

4 rounds · quality: 0.50

Theorist

# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration --- ## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification **Descripti...

Skeptic

# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...

Domain Expert

# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration ## Executive Summary The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...

Synthesizer

```json { "ranked_hypotheses": [ { "rank": 1, "id": "Hypothesis_1", "title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification", "targe...

Price History Overlay

Knowledge Graph Comparison

CX3CL1 Mimetic Peptide to Disrupt Fracta

5 edges
Top Node Types
mechanism5
Top Relations
implicates_in5

Circulating hs-CRP as Disease-Modifying

5 edges
Top Node Types
mechanism5
Top Relations
implicates_in5